KCT0001172进行中（未招募）未知
An Open-Label, Multiple-Dose, Two-Arm Clinical Study to Evaluate the Drug-Drug Interaction and Safety of Telmisartan, Amlodipine and/or Chlorthalidone in Healthy Adult Volunteers
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- Yuhan
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 45(Year)（—）
- 性别
- All
入选标准
- •1.Participant who has a body weight that is >=55kg(male) or >=50kg(female) with ideal bosy weight of 80-120%
- •2.Who has not suffered from clinically significant disease
- •3.Provision of signed written informed consent
排除标准
- •1.History of and clinically significant disease
- •2.A history of drug abuse or the presence of positive reactions to drugs that have abuse potential in urine screenings for drugs
- •3.Administration of other investigational products within 3 months prior to the first dosing.
- •4.Administration of herbal medicine within 2 weeks or administration of ethical drugs within 2 weeks or administration of over-the-counter (OTC) drugs within 1 week prior to the first dosing of the investigational product (if the investigator (study doctor) determines that the person meets other criteria appropriately, the relevant person may participate in the study).
- •5.Volunteers considered not eligible for the clinical trial by the investigator (study doctor) due to reasons including laboratory test results, ECGs, or vital signs.
研究者
相似试验
已完成
不适用
Study to evaluate the safety and pharmacokinetics after co-administration of UIC201601 and UIC201602Endocrine, nutritional and metabolic diseasesKCT0007411Korea United Pharm40
招募中
不适用
To investigate the pharmacokinetic drug interaction between Pitavastatin and Ezetimibe after oral administration in healthy volunteersEndocrine, nutritional and metabolic diseasesKCT0007827Kuhnil Pharm.56
已完成
不适用
A randomized, open-label, multiple-dose, two-arm, one-sequence?crossover study to evaluate the safety and pharmacokinetics after oral concurrent administration telmisartan/s-amlodipine and rosuvastatin in healthy volunteersKCT0001086Chong Kun Dang64
尚未招募
不适用
An Open-label, Parallel, Single-Dose, Clinical Study after administration of WS1313D in Children and Adolescent with Pain to Evaluate Pharmacokinetics (PK) / Pharmacodynamics (PD) and SafetyKCT0004166Woosung Pharma62
已完成
不适用
An open-label, multiple-dose, sequential, 2 treatment period study to evaluate the effect of QBW251 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in pre-menopausal healthy female volunteersCFmucoviscidosis1004078910013326NL-OMON40637ovartis47